loadpatents
name:-0.0012140274047852
name:-0.022871017456055
name:-0.00072598457336426
Umezawa; Sumio Patent Filings

Umezawa; Sumio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Umezawa; Sumio.The latest application filed is for "1-n-(.omega.-amino-.alpha.-hydroxyalkanoyl-2',3'-dideoxykanamycin a and pharmaceutical composition containing same".

Company Profile
0.18.0
  • Umezawa; Sumio - Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1-N-(.omega.-Amino-.alpha.-hydroxyalkanoyl-2',3'-dideoxykanamycin A and pharmaceutical composition containing same
Grant 4,547,492 - Umezawa , et al. October 15, 1
1985-10-15
3',4'-Dideoxykanamycin A and 1-N-(S)-.alpha.-hydroxy-.omega.-aminoalkanoyl) derivatives thereof
Grant 4,298,727 - Umezawa , et al. November 3, 1
1981-11-03
Production of a selectively protected N-acylated derivative of an aminoglycosidic antibiotic
Grant 4,297,485 - Umezawa , et al. October 27, 1
1981-10-27
Novel macrolactone derivatives and process of producing them
Grant 4,196,280 - Umezawa , et al. April 1, 1
1980-04-01
3',4'-Episulfido kanamycin B compounds
Grant 4,195,170 - Umezawa , et al. March 25, 1
1980-03-25
Derivatives of kanamycin A
Grant 4,170,642 - Umezawa , et al. October 9, 1
1979-10-09
Process for the synthesis of 3',4'-dideoxykanamycin B and products
Grant 4,156,078 - Umezawa , et al. May 22, 1
1979-05-22
Novel process for the preparation of 1-N-(alpha-substituted-omega-aminoacyl)-3'-deoxyribostamycin
Grant 4,125,706 - Umezawa , et al. November 14, 1
1978-11-14
1-N-[(S)-.alpha.-hydroxy-.omega.-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
Grant 4,107,424 - Umezawa , et al. August 15, 1
1978-08-15
N-methanesulfonic acid derivatives of 3',4'-dideoxykanamycin B
Grant 4,091,202 - Umezawa , et al. May 23, 1
1978-05-23
3'-Epi-4'deoxykanamycin B
Grant 4,078,138 - Akita , et al. March 7, 1
1978-03-07
Processes for production of a 1-N-(.alpha.-hydroxy-.PHI.-amino alkanoyl)-3-deoxy-5-O-pentafuranosyl neamine and new compounds produced by the same processes
Grant 4,065,616 - Umezawa , et al. December 27, 1
1977-12-27
1-N-[(S)-.alpha.-hydroxy-.omega.-aminoacyl]
Grant 4,001,208 - Umezawa , et al. January 4, 1
1977-01-04
New compound 6'-deoxy-'-substituted or unsubstituted amino-lividomycins and the production thereof
Grant 3,956,274 - Umezawa , et al. May 11, 1
1976-05-11
3'-Deoxy derivatives of neamine and its related aminoglycosidic antibiotics, and the production thereof
Grant 3,929,762 - Umezawa , et al. December 30, 1
1975-12-30
Process for the production of an 1-n-(s)-alpha- substituted-w-aminoacyl) derivative of neamine, 3', 4'-dideoxyneamine, ribostamycin or 3',4'-dideoxyribostamycin
Grant 3,925,354 - Umezawa , et al. December 9, 1
1975-12-09
4-0-(6-Alkylamino-6-deoxy-alpha-D-hexopyranosyl)-deoxystreptamine derivatives and the production thereof
Grant 3,925,353 - Umezawa , et al. December 9, 1
1975-12-09
Preparation of 3-4 dideoxykanamycin B active against resistant bacteria
Grant RE28,647 - Umezawa , et al. December 9, 1
1975-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed